subject area of
- A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients Journal Articles
-
Final report of
TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD ) study Journal Articles - Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors Journal Articles
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease Journal Articles